Aqr Capital Management LLC Intellia Therapeutics, Inc. Transaction History

Aqr Capital Management LLC

$71.5 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$53.92 - $71.7 $174,161 - $231,591	-3,230 Reduced 39.02%	5,048 $282,000
Q2 2022 Aug 15, 2022	SELL	$38.49 - $76.21 $681,542 - $1.35 Million	-17,707 Reduced 68.14%	8,278 $428,000
Q1 2022 May 16, 2022	SELL	$58.27 - $118.99 $857,443 - $1.75 Million	-14,715 Reduced 36.15%	25,985 $1.89 Million
Q4 2021 Feb 14, 2022	SELL	$100.76 - $138.36 $682,850 - $937,665	-6,777 Reduced 14.27%	40,700 $4.81 Million
Q3 2021 Nov 15, 2021	BUY	$132.37 - $176.78 $1.58 Million - $2.1 Million	11,901 Added 33.45%	47,477 $6.37 Million
Q2 2021 Aug 16, 2021	BUY	$60.88 - $161.91 $235,727 - $626,915	3,872 Added 12.21%	35,576 $5.76 Million
Q1 2021 May 17, 2021	BUY	$46.59 - $83.68 $531,778 - $955,123	11,414 Added 56.25%	31,704 $2.54 Million
Q4 2020 Feb 16, 2021	SELL	$18.83 - $63.53 $102,698 - $346,492	-5,454 Reduced 21.19%	20,290 $1.1 Million
Q3 2020 Nov 16, 2020	BUY	$17.47 - $24.93 $90,302 - $128,863	5,169 Added 25.12%	25,744 $512,000
Q2 2020 Aug 17, 2020	SELL	$11.14 - $22.87 $261,210 - $536,255	-23,448 Reduced 53.26%	20,575 $432,000
Q1 2020 May 15, 2020	SELL	$9.44 - $15.58 $147,396 - $243,266	-15,614 Reduced 26.18%	44,023 $538,000
Q4 2019 Feb 14, 2020	BUY	$10.43 - $17.67 $240,922 - $408,159	23,099 Added 63.22%	59,637 $875,000
Q3 2019 Nov 14, 2019	BUY	$13.07 - $18.51 $477,551 - $676,318	36,538 New	36,538 $488,000
Q4 2018 Feb 14, 2019	SELL	$11.39 - $27.13 $119,811 - $285,380	-10,519 Closed	0 $0
Q3 2018 Nov 15, 2018	BUY	$25.78 - $32.6 $27,197 - $34,393	1,055 Added 11.15%	10,519 $301,000
Q2 2018 Aug 14, 2018	SELL	$20.02 - $30.79 $106,646 - $164,018	-5,327 Reduced 36.02%	9,464 $259,000
Q1 2018 May 15, 2018	BUY	$19.43 - $34.95 $287,389 - $516,945	14,791 New	14,791 $312,000
Q4 2017 Feb 14, 2018	SELL	$17.39 - $31.12 $393,709 - $704,556	-22,640 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$15.16 - $25.75 $343,222 - $582,980	22,640	22,640 $563,000

Others Institutions Holding NTLA

# of Institutions

314

Shares Held

91.5M

Call Options Held

442K

Put Options Held

880K

Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

12.3M
Shares

$149 Million
2.39% of portfolio
Vanguard Group Inc Valley Forge, PA

9.63M
Shares

$117 Million
0.0% of portfolio
Black Rock Inc. New York, NY

9.6M
Shares

$117 Million
0.0% of portfolio
State Street Corp Boston, MA

5.14M
Shares

$62.6 Million
0.0% of portfolio
Deep Track Capital, LP Greenwich, CT

4.95M
Shares

$60.3 Million
3.75% of portfolio

View Full List

About Intellia Therapeutics, Inc.

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $926M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

More about NTLA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.

Account